Adding interferon to lamivudine enhances the early virologic response and reversion of the precore mutation in difficult-to-treat HBV infection

スポンサーリンク

概要

• 論文の詳細を見る
• 2008-06-01

著者

• KATO Michio

  Department of Gastroenterology, National Hospital Organization Minamiwakayama Medical Center

• Omura Masao

  Srl Inc.

• Kato Michio

  Department Of Gastroenterology National Hospital Organization Minamiwakayama Medical Center

• YUKI Nobukazu

  Department of Gastroenterology, Osaka National Hospital

• Yuki Nobukazu

  Department Of Gastroenterology Osaka National Hospital

• NAGAOKA TAKAYUKI

  SRL Inc.

• NUKUI KAZUHIKO

  Department of Medical Information, Dainippon Sumitomo Pharma Co., Ltd.

• HIKIJI KAZUMASA

  SRL Inc.

• Nukui Kazuhiko

  Department Of Medical Information Dainippon Sumitomo Pharma Co. Ltd.

• Kato Michio

  Department Of Electrical Engineering National Defense Academy

• Nukui Kazuhiko

  Department of Chemistry, Faculty of Science, Kanazawa University

関連論文

• Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
• Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B
• Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
• Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma
• Early emergence of entecavir-resistant hepatitis B virus in a patient with hepatitis B virus/human immunodeficiency virus coinfection
• Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine
• Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
• Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C
• Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?
• The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan
• Juvenile hepatocellular carcinoma with congestive liver cirrhosis
• Sequencing analysis of the terminal protein region in patients showing persistent remission of chronic hepatitis B
• Pretreatment viral load and response to interferon therapy for liver cirrhosis caused by hepatitis C virus: a multicenter controlled study
• Roles of double-balloon endoscopy in the diagnosis and treatment of Crohn's disease : a multicenter experience
• Chronic hepatitis C in patients co-infected with human immunodeficiency virus in Japan : a retrospective multicenter analysis
• Prevalence of hepatitis B virus infection in Japanese patients with HIV
• Squamous cell carcinoma as a rare entity of primary liver tumor with grave prognosis
• Endoscopic follow-up study of development of gastric antral vascular ectasia associated with liver cirrhosis
• Changes in virus loads and precore mutations in chronic hepatitis B patients treated with 4 weeks of daily interferon alfa-2a therapy
• Thrombotic thrombocytopenic purpura developed suddenly during interferon treatment for chronic hepatitis C
• Experimental Studies on Potentiation of the Antitumor Activity of 5-Fluorouracil with 3'-Azido-3'-deoxythymidine for the Gastric Cancer Cell Line MKN28 in vivo
• Circulating soluble Fas levels in patients with hepatitis C virus infection and interferon therapy
• EFFECT OF ENDOSCOPIC TREATMENT OF GASTRIC ANTRAL VASCULAR ECTASIA ASSOCIATED WITH CHRONIC LIVER DISEASE
• Adding interferon to lamivudine enhances the early virologic response and reversion of the precore mutation in difficult-to-treat HBV infection
• Late Cenozoic Micropaleontologic Events in the Equatorial Pacific Sediments
• A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis
• Output Power and Frequency-Pulling in a Partially Homogeneously Broadened, Saturated Single-Mode Ring Laser : Analytical Formulas
• Endoscopic submucosal dissection as a treatment for gastric noninvasive neoplasia : a multicenter study by Osaka University ESD Study Group
• The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan
• Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan
• Association of low serum adiponectin levels with erosive esophagitis in men : an analysis of 2405 subjects undergoing physical check-ups
• Reducing Peg-IFN doses causes later virologic response or no response in HCV genotype 1 patients treated with Peg-IFN alfa-2b plus ribavirin
• Vacuum sublimation behavior of iron(III), cobalt(II), nickel(II), copper(II), and palladium(II) chelates with tetradentate N,N'-disalicylideneethylenediamine and N,N'-bis(1-methyl-3-oxobutylidene)ethylenediamine.
• Chronic hepatitis B in patients coinfected with human immunodeficiency virus in Japan : a retrospective multicenter analysis

もっと見る 閉じる

スポンサーリンク